Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F8EC3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,457
Award facts
- Contract value 100% obligated
- $12,456.93 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Dupixent 300 mg/2 ml pen injections with a ceiling value of $12,456.93. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The order is expected to be completed by December 9, 2025, with performance at AmerisourceBergen's Conshohocken, Pennsylvania location. Dupixent (dupilumab) is a biologic medication used to treat various inflammatory conditions including atopic dermatitis, asthma, and eosinophilic disorders.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen supplies a broad range of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to support military and veteran healthcare systems worldwide. The company's extensive federal procurement portfolio demonstrates its capability to fulfill diverse medical supply requirements through competitive contracting processes, supporting customers including the Defense Health Agency and U.S. Coast Guard.
Quick answers
Who was awarded contract SPE2DR26F8EC3?
SPE2DR26F8EC3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 8, 2025.
How much is contract SPE2DR26F8EC3 worth?
The government has obligated $12,457 on SPE2DR26F8EC3.
Is contract SPE2DR26F8EC3 an order under another contract?
Yes. SPE2DR26F8EC3 is a delivery order under SPE2DR25D3110, an indefinite delivery contract.
Was contract SPE2DR26F8EC3 competed?
The extent of competition for SPE2DR26F8EC3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award